The acceleration of the market globalisation process over the last three decades has internationalised clinical research and influenced both the way in which it is funded and the development and application of research practices. In addition, in recent years international multicentre randomised clinical trials have become the model par excellence for research on new medicines. The neoliberal model of globalisation has induced a decline in state power, both with regard to establishing national research for health priorities and to influencing the development of adequate ethical guidelines to protect human beings that participate in multinational research. In this respect, poor and low-income countries, which lack sustainable control and review systems to deal with the ethical and methodological challenges of complex studies conducted by researchers from affluent countries and funded by large multinational pharmaceutical companies, are particularly vulnerable. The aim of the present paper is to explore critically some of the actual and possible ethical pitfalls of globalisation of clinical research and propose mechanisms for turning transnational clinical research into a more cooperative and fairer enterprise.
- Benefit sharing
- clinical ethics
- double standards
- human rights
- social vulnerability
- scientific research
- ethics committees/consultation
- social aspects
- social control of human experimentation
- cultural pluralism
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Hidden risks associated with clinical trials in developing countries
- It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North–South collaborative trials
- Responsibilities in international research: a new look revisited
- Regulating international clinical research: an ethical framework for policy-makers
- Glossary of the World Trade Organisation and public health: part 1
- Who is my brother's keeper?
- An analysis of tax abuse, debt, and climate change risk in low-income and lower-middle-income countries
- International palliative care research in the context of global development: a systematic mapping review
- Double standards in healthcare innovations: the case of mosquito net mesh for hernia repair
- Economic globalisation and its effect on health